Roche recently announced that its product Evrysdi (risdiplam) was recommended for approval for the treatment of spinal muscular atrophy (SMA) in patients two months of age and older by the...
Despite the theoretical potential of inactivated virus vaccines to offer a lead over other Covid-19 vaccine technologies against variants of…
Eli Lilly and Company has reported that results from the SURPASS-2 clinical trial of tirzepatide showed superior A1C and body weight reductions from baseline in…
Apollomics has dosed the first patient in a Phase I clinical trial of an investigational drug candidate, APL-106 (uproleselan injection), for treating adults with relapsed…
Dicerna Pharmaceuticals and Roche have commenced the Phase II combination trial of investigational GalXC RNAi candidate, RG6346, for treating chronic…
Marker Therapeutics has treated the first patient in its Phase II trial of its lead MultiTAA-specific T cell product candidate…
Eli Lilly and Company and Incyte have reported positive top-line results from Phase III BRAVE-AA2 study of baricitinib, which demonstrated…
Vir Biotechnology and GlaxoSmithKline (GSK) have reported that an independent Data and Safety Monitoring Board (DSMB) has recommended halting enrolment…
High-prescribing physicians who routinely use immuno-oncology (IO) agents in their practice ranked the combination of co-inhibitory and co-stimulatory checkpoint modulation as the most important R&D strategy that the industry should…
The top cardiovascular tweeted terms are the trending industry discussions happening on Twitter by key individuals (influencers) as tracked by the platform. 1. Imaging – 698 mentions Nanox’s innovation in…
With the Covid-19 pandemic recently passing one year in duration, clinical research continues to be significantly affected. The most prominent disruptions involve site closures, patient enrollment and retention issues, R&D…
The COVID-19 pandemic has led to a surge in the use of remote patient monitoring (RPM) tools to monitor patients...
The COVID-19 pandemic triggered unexpected challenges in the business environment prompting pharmaceutical companies to accelerate the adoption of digital transformation strategies.
The COVID-19 pandemic has led to an increase in investments in digital transformation and emerging technologies to deal with the shift towards remote working and...
The UK government has banned Chinese technology firm Huawei from providing telecommunications equipment to the UK’s mobile 5G network from the start of 2021.
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
UK Covid-19 Vaccine Administration at 300 shots per 1,000 population, while vaccine rates low elsewhere in europe
With new SARS-CoV-2 variant strains appearing, the global race to control the COVID-19 pandemic through immunization is on. Europe remains one of the worst affected regions in the world, now…